Standout Papers

An overview of prevalence, determinants and health outcomes of polypharmacy 2020 2026 2022 2024228
  1. An overview of prevalence, determinants and health outcomes of polypharmacy (2020)
    Mina Khezrian, Christopher J. McNeil et al. Therapeutic Advances in Drug Safety

Immediate Impact

19 standout
Sub-graph 1 of 9

Citing Papers

Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
2025 Standout
Vitamin D and Colorectal Cancer Prevention: Immunological Mechanisms, Inflammatory Pathways, and Nutritional Implications
2025 Standout
2 intermediate papers

Works of Mina Khezrian being referenced

An overview of prevalence, determinants and health outcomes of polypharmacy
2020 Standout
Aspirin moderates the association between cardiovascular risk, brain white matter hyperintensity total lesion volume and processing speed in normal ageing
2020

Author Peers

Author Last Decade Papers Cites
Mina Khezrian 222 36 117 87 10 337
Gabriel Ariza‐Zafra 270 37 153 70 11 305
Laurie E. Davies 226 15 130 80 10 310
Robert Prowse 270 43 151 43 11 369
Dana Clarissa Muhlack 213 26 124 86 8 332
Victor Crentsil 193 55 80 91 16 406
F. Andreasen 159 34 70 41 11 324
Helene G. van der Meer 261 10 140 86 11 315
Chiung‐Jung Wen 157 53 70 64 28 371
Liesa Katharina Hoppe 214 15 123 91 11 329
Anna Vögele 234 19 134 88 18 400

All Works

Loading papers...

Rankless by CCL
2026